The largest database of trusted experimental protocols

Complementary oligos

Manufactured by Integrated DNA Technologies

Complementary oligos are synthetic DNA or RNA sequences designed to bind to a specific target sequence. They are used in various molecular biology applications such as gene expression analysis, PCR, and hybridization techniques.

Automatically generated - may contain errors

5 protocols using complementary oligos

1

Cloning Cas9/gRNA Constructs for CRISPR Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CRISPR gRNAs used in SGE and essentiality experiments were cloned into pX45924 (link). This plasmid expresses the gRNA from a U6 promoter, as well as a Cas9–2A-puromycin resistance (-puroR) cassette. S. pyogenes Cas9 target sites were chosen for SGE experiments on multiple criteria, assessed in the following order: 1.) To induce cleavage within BRCA1 coding sequence, 2.) To target a genomic site permissive to synonymous substitution within the guanine dinucleotide of the PAM or the protospacer, 3.) To have minimal predicted off-target activity47 (link), 4.) To have maximal predicted on-target activity48 (link).
Complementary oligos ordered from Integrated DNA Technologies (IDT) were annealed, phosphorylated, diluted and ligated into BbsI-digested and gel-purified pX459, as described24 (link). Ligation reactions were transformed into E. coli (Stellar competent cells, Takara), which were plated on ampicillin. Colonies were cultured and Sanger sequenced to confirm correct gRNA sequences. Purification of sequence-verified plasmids for transfection was performed with the ZymoPure Maxiprep kit (ZymoResearch). For targeting LIG4 in HAP1 cells, pX45824 (link) was used instead of pX459, which expresses EGFP in lieu of puroR.
+ Open protocol
+ Expand
2

8-oxoG Cleavage Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained 31-mer oligos containing 8-oxoG at position X and complementary oligos with a C opposite X from Integrated DNA Technologies (Coralville, IA). The oligo sequence was 5′-GTGACTACGAGACCTXATGTGACTGAGAGAG- 3′, as previously described [105] (link). Cleavage reactions with bacterially purified proteins were conducted using 50 nM of proteins and 0.08 U of human OGG1 (New England Biolabs) in 25 mM NaCl, 10 mM Tris (pH 7.5), 1 mM MgCl2, 5 mM EDTA (pH 8.0), 5% glycerol, 1 mM of DTT, and 1 pmol of 32P radiolabeled double-stranded oligonucleotides containing an 8-oxoG base (Figure S5). Reactions with total cell extracts were performed as described by [106] (link). In both assays, cleavage reactions were performed at 37°C as previously described. The DNA was loaded on a prewarmed 20% polyacrylamide-urea gel (19∶1) and separated by electrophoresis in Tris-borate and EDTA (TBE; pH 8.0) at constant 20 mAmp. The radiolabeled DNA fragments were visualized by storage phosphor screen (GE Healthcare).
+ Open protocol
+ Expand
3

Cloning Strategy for SPA4CT Sequence

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cloning strategy was designed and implemented to generate the SPA4CT sequence (25 (link)). pLVX APP-770 was digested with EcoRI and NotI to generate a 366 base pair terminal APP insert. Complementary oligos (purchased from Integrated DNA Technologies) were annealed to form an insert with XhoI and EcoRI overhangs. pLVX was digested with XhoI and NotI and religated together with the two inserts. For specific sequences, see Supplementary Table S4. SPA4CT-T43P was generated using the Q5 Site-Directed Mutagenesis Kit (NEB E0554S) using pLVX SPA4CT as a template. For specific sequences of primers and inserts, please see Supplementary Table S4.
+ Open protocol
+ Expand
4

Cloning Cas9/gRNA Constructs for CRISPR Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CRISPR gRNAs used in SGE and essentiality experiments were cloned into pX45924 (link). This plasmid expresses the gRNA from a U6 promoter, as well as a Cas9–2A-puromycin resistance (-puroR) cassette. S. pyogenes Cas9 target sites were chosen for SGE experiments on multiple criteria, assessed in the following order: 1.) To induce cleavage within BRCA1 coding sequence, 2.) To target a genomic site permissive to synonymous substitution within the guanine dinucleotide of the PAM or the protospacer, 3.) To have minimal predicted off-target activity47 (link), 4.) To have maximal predicted on-target activity48 (link).
Complementary oligos ordered from Integrated DNA Technologies (IDT) were annealed, phosphorylated, diluted and ligated into BbsI-digested and gel-purified pX459, as described24 (link). Ligation reactions were transformed into E. coli (Stellar competent cells, Takara), which were plated on ampicillin. Colonies were cultured and Sanger sequenced to confirm correct gRNA sequences. Purification of sequence-verified plasmids for transfection was performed with the ZymoPure Maxiprep kit (ZymoResearch). For targeting LIG4 in HAP1 cells, pX45824 (link) was used instead of pX459, which expresses EGFP in lieu of puroR.
+ Open protocol
+ Expand
5

Lentiviral CRISPR-Cas9 Knockdown of MTA1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The online guide design tool from DNA 2.0 gRNA (now known as ATUM, Newark, CA) was used to identify sgRNAs. The DNA sequence corresponding to the annotated stem loop miRNA (www.miRBase.org) was used as an input sequence. The highest scoring guides and/or those closest to the mature miRNA sequence were selected. Complementary oligos containing the sgRNA sequence and BsmBI overhangs were synthesized (Integrated DNA Technologies), annealed, digested with BsmBI and ligated into the lentiCRISPR v2, a gift from Feng Zhang (Addgene, # 52961) [20 (link)]. MTA1-sgRNA-1: 5′- CTCCAAGGCCATCTCGGCGC-3′; MTA1-sgRNA-3: 5′- CAGCTGCGGCGCTCATGTGC-3 and MTA1-sgRNA-5: 5’-CTCTGTGGGCACCTTCGCAC-3′. MCF7 and MDA-MB-231 cells were infected with lentivirus in the presence of 8 μg/ml polybrene (Sigma-Aldrich). Approximately 48 h post-infection cells were selected by treating with 1 μg/ml puromycin (InvivoGen, San Diego, CA) for 3 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!